Presentation is loading. Please wait.

Presentation is loading. Please wait.

Treatment of Dyslipidemia in Allogeneic Hematopoietic Stem Cell Transplant Patients  Bernard Lawrence Marini, Sung Won Choi, Craig Alan Byersdorfer, Simon.

Similar presentations


Presentation on theme: "Treatment of Dyslipidemia in Allogeneic Hematopoietic Stem Cell Transplant Patients  Bernard Lawrence Marini, Sung Won Choi, Craig Alan Byersdorfer, Simon."— Presentation transcript:

1 Treatment of Dyslipidemia in Allogeneic Hematopoietic Stem Cell Transplant Patients 
Bernard Lawrence Marini, Sung Won Choi, Craig Alan Byersdorfer, Simon Cronin, David G. Frame  Biology of Blood and Marrow Transplantation  Volume 21, Issue 5, Pages (May 2015) DOI: /j.bbmt Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

2 Biology of Blood and Marrow Transplantation 2015 21, 809-820DOI: (10
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

3 Figure 1 Mechanism of statin immunomodulation in GVHD [17,55-58,60,61]. Treg indicates regulatory T cell; LFA1, leukocyte function-associated antigen-1; ICAM, intercellular adhesion molecule; CIIA, MHC class II transactivator; TCR, T cell receptor; MHCII, MHC complex class II; PP, pyrophosphate. Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions


Download ppt "Treatment of Dyslipidemia in Allogeneic Hematopoietic Stem Cell Transplant Patients  Bernard Lawrence Marini, Sung Won Choi, Craig Alan Byersdorfer, Simon."

Similar presentations


Ads by Google